Australia markets closed

Advanced Proteome Therapeutics Corporation (0E81.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
0.00300.0000 (0.00%)
As of 09:15AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/07/2022
31/07/2021
31/07/2020
31/07/2019
Total revenue
0
0
0
0
0
Operating expenses
Research development
595.259
687.497
390.683
-
-
Selling general and administrative
329.753
253.362
259.825
547.612
888.597
Total operating expenses
950.596
959.827
673.968
569.938
926.082
Operating income or loss
-950.596
-959.827
-673.968
-569.938
-926.082
Interest expense
35.923
29.096
27.406
29.531
22.958
Total other income/expenses net
-1,225
1,584
-1,220
57.975
487.671
Income before tax
-2,211
597.482
-1,920
-541.494
-461.369
Income from continuing operations
-2,211
597.482
-1,920
-541.494
-461.369
Net income
-2,042
759.615
-1,835
-450.636
-333.466
Net income available to common shareholders
-2,042
759.615
-1,835
-450.636
-333.466
Basic EPS
-0.06
0.01
-0.06
-0.02
-0.02
Diluted EPS
-0.06
0.01
-0.06
-0.02
-0.02
Basic average shares
40,193
39,088
31,706
22,158
17,282
Diluted average shares
40,193
39,088
31,706
22,158
17,282